Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses
Open Access
- 13 June 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (6) , 1084
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggers disease with nonspecific symptoms that overlap those of infections caused by other seasonal respiratory viruses (RVs), such as the influenza virus (Flu) or respiratory syncytial virus (RSV). A molecular assay for accurate and rapid detection of RV and SARS-CoV-2 is crucial to manage these infections. Here, we compared the analytical performance and clinical reliability of Allplex™ SARS-CoV-2/FluA/FluB/RSV (SC2FabR; Seegene Inc., Seoul, South Korea) kit with those of four commercially available RV detection kits. Upon testing five target viral strains (SARS-CoV-2, FluA, FluB, RSV A, and RSV B), the analytical performance of SC2FabR was similar to that of the other kits, with no significant difference (p ≥ 0.78) in z-scores. The efficiency of SC2FabR (E-value, 81–104%) enabled reliable SARS-CoV-2 and seasonal RV detection in 888 nasopharyngeal swab specimens processed using a fully automated nucleic acid extraction platform. Bland–Altman analyses revealed an agreement value of 95.4% (SD ± 1.96) for the kits, indicating statistically similar results for all five. In conclusion, SC2FabR is a rapid and accurate diagnostic tool for both SARS-CoV-2 and seasonal RV detection, allowing for high-throughput RV analysis with efficiency comparable to that of commercially available kits. This can be used to help manage respiratory infections in patients during and after the coronavirus disease 2019 pandemic.Keywords
This publication has 31 references indexed in Scilit:
- Polymerase Chain Reaction (PCR) Amplification of GC-Rich TemplatesCold Spring Harbor Protocols, 2019
- The rapid diagnosis of viral respiratory tract infections and its impact on antimicrobial stewardship programsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Comparison of the Luminex xTAG Respiratory Viral Panel Fast v2 Assay With Anyplex II RV16 Detection Kit and AdvanSure RV Real-Time RT-PCR Assay for the Detection of Respiratory VirusesAnnals of Laboratory Medicine, 2017
- Impact of Rapid Molecular Respiratory Virus Testing on Real-Time Decision Making in a Pediatric Emergency DepartmentThe Journal of Molecular Diagnostics, 2017
- Performance Evaluation of Allplex Respiratory Panels 1, 2, and 3 for Detection of Respiratory Viruses and Influenza A Virus SubtypesJournal of Clinical Microbiology, 2017
- In Silico PCR Primer Designing and Validation2015
- Comparison of three multiplex PCR assays for the detection of respiratory viral infections: evaluation of xTAG respiratory virus panel fast assay, RespiFinder 19 assay and RespiFinder SMART 22 assayBMC Infectious Diseases, 2012
- Prospective evaluation of a new automated nucleic acid extraction system using routine clinical respiratory specimensJournal of Medical Virology, 2012
- Molecular detection of tyrosinase transcripts in peripheral blood from patients with malignant melanoma: correlation of PCR sensitivity threshold with clinical and pathologic disease characteristicsClinical Chemistry and Laboratory Medicine (CCLM), 2006
- Analysis of Microarray Data Using Z Score TransformationThe Journal of Molecular Diagnostics, 2003